Erythema Dyschromicum Perstans Response to Isotretinoin

JAMA Dermatol. 2016 Jul 1;152(7):841-2. doi: 10.1001/jamadermatol.2015.6185.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Chronic Disease
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Erythema / drug therapy*
  • Erythema / pathology*
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / pathology
  • Follow-Up Studies
  • Humans
  • Hyperpigmentation / drug therapy*
  • Hyperpigmentation / pathology
  • Immunohistochemistry
  • Isotretinoin / therapeutic use*
  • Male
  • Middle Aged
  • Recurrence
  • Retreatment
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Substances

  • Isotretinoin